Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Embarassed

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on May 07, 2021 1:15pm

166 Views

Post# 33153188

RE:Embarassed

Let's hope your patience and willingness pays off this year and when you go see him in the winter, the converation will be what to do with all those profits! Maybe you can mix in a "told you so...."

longterm56 wrote: I'm phasing into retirement and should really be chatting with my financial advisor, but I'm too embarassed to talk with him because his last advice was "lighten up on your THTX holdings!!!" Well, when you look at how THTX has performed in the last two years compared with almost ANYTHING else ... well, it's embarassing.

-LT

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks